LRE1

CAS No. 1252362-53-0

LRE1( —— )

Catalog No. M26744 CAS No. 1252362-53-0

LRE1 is a specific and allosteric soluble adenylyl cyclase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 Get Quote
10MG 87 Get Quote
25MG 170 Get Quote
50MG 320 Get Quote
100MG 476 Get Quote
500MG 1062 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LRE1
  • Note
    Research use only, not for human use.
  • Brief Description
    LRE1 is a specific and allosteric soluble adenylyl cyclase inhibitor.
  • Description
    LRE1 is a specific and allosteric soluble adenylyl cyclase inhibitor.(In Vitro):LRE1 prevents sAC-dependent processes in cellular and physiological systems and facilitates exploration of the therapeutic potential of sAC inhibition. LRE1 binds to the bicarbonate activator binding site and suppresses soluble adenylyl cyclase (sAC) via a unique allosteric mechanism.
  • In Vitro
    Western Blot Analysis Cell Line:Mouse cauda sperm Concentration:0.5-100 μM Incubation Time:60 minutes Result:LRE1 inhibits sAC dependent sperm capacitation.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    S1PR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1252362-53-0
  • Formula Weight
    280.77
  • Molecular Formula
    C12H13ClN4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (445.19 mM)
  • SMILES
    Nc1nc(Cl)cc(n1)N(Cc1cccs1)C1CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bigaud M, et al. Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism. PLoS One. 2016 Dec 22;11(12):e0168252.
molnova catalog
related products
  • 2-Deoxy-D-ribose

    2-Deoxy-D-ribose induces apoptosis by inhibiting the synthesis and increasing the efflux of glutathione.

  • L524-0366

    L524-0366 is a TWEAK-Fn14 signaling cascade inhibitor.L524-0366 mitigated maladaptive remodeling with TAC. TWEAK induced secretion of the pro-inflammatory chemokine, monocyte chemoattractant protein 1 from WT but not Fn14-/-?fibroblasts in vitro, in part through activation of non-canonical NF-κB signaling.

  • Fibrinogen Binding I...

    Fibrinogen Binding Inhibitor Peptide, a synthetic dodecapeptide, represents the specific platelet receptor recognition site of the human fibrinogen g-chain (residues 400-411).